Skip to main content
Clinical Trials/KCT0008359
KCT0008359
Recruiting
未知

Aggressive hydration with lactated Ringer’s solution versus Plasma solution for the prevention of post ERCP (Endoscopic Retrograde Cholangiopancreatography) pancreatitis : Multicenter, Double blind, Randomized controlled trial

Asan Medical Center0 sites844 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Asan Medical Center
Enrollment
844
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional Study
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Intact major papilla in patients with preserved papilla due to non\-ERCP Enroll patients who agree to clinical trials if they are at average \~ high risk of pancreatitis (if one or more of the following items applies) after endoscopic retrograde cholangiopancreatography
  • 1\.40 years of age or younger
  • 2\.(Suspected) Sphincter of oddi dysfunction
  • 3\.The normal level of serum total bilirubin
  • 4\.History of recurrent pancreatitis
  • 5\.Require injection of a contrast agent into the pancreatic duct
  • 6\.Require endoscopic biliary or pancreatic sphincterotomy
  • 7\.Require precut sphincterotomy
  • 8\.Require endoscopic papillary balloon dilation
  • 9\.Planned endoscopic papillectomy

Exclusion Criteria

  • Exclusion criteria for research subjects : Exclude any of the following items if applicable.
  • 1\.Not consented to study participation
  • 2\.18 years of age or younger
  • 3\.Severe comorbidities (e.g., end\-stage kidney disease, end\-stage chronic obstructive pulmonary disease, hypoglycemic dysregulation, decompensated liver cirrhosis)
  • 4\.Sepsis (defined as meeting two or more of the following items):
  • v Body temperature \>38\.3ºC or \<36ºC
  • v Heart rate \>90 beats/min
  • v Tachypnea (respiratory rate \> 20 breaths/min)
  • v Leukocytosis (WBC \>12,000 /uL) or leukopenia (WBC \<4000 /uL)
  • 5\.Acute pancreatitis

Outcomes

Primary Outcomes

Not specified

Similar Trials